English
Español de México
Português
Français
The most DS-specific target: RCAN1
RCAN1 (also called DSCR1) sits in the Down syndrome critical region on chromosome 21. Extra copy number raises RCAN1 protein, which:
• increases mitochondrial and cellular ROS,
• activates NF-κB,
• induces the apoptosis adaptor Nucling,
• releases cytochrome c and activates caspase-3.
In neuronal cells engineered to overexpress RCAN1, lycopene lowered ROS, blocked NF-κB and Nucling, preserved mitochondrial membrane potential and respiration, and reduced apoptotic death. Serum lycopene is also reported to be low in people with DS and AD, which is consistent with higher oxidative consumption or lower intake. onlinelibrary.wiley.com
That is the closest thing to a “gene-expression / dosage-sensitive pathway” story for lycopene in DS. It does not turn RCAN1 transcription off; it blunts the downstream damage of too much RCAN1 protein.
Other DS-relevant pathways lycopene can touch
These are better documented in AD and oxidative-stress models than in DS itself, but they overlap heavily with trisomy 21 biology.
Redox imbalance from SOD1. Extra SOD1 converts more superoxide to hydrogen peroxide than catalase and glutathione peroxidase can clear. Lycopene is a lipid-phase singlet-oxygen quencher (11 conjugated double bonds). It can reduce lipid peroxidation (HNE, MDA) that is already elevated in DS amniotic fluid and later brain. It can also activate Nrf2 via PI3K/Akt, raising endogenous antioxidant enzymes (SOD, GPx, HO-1). pmc.ncbi.nlm.nih.gov
APP / Aβ axis. Lycopene has been shown in AD cell and rat models to:
• lower BACE activity,
• reduce Aβ accumulation,
• raise LRP1 and lower RAGE at the choroid plexus (favoring Aβ export from CSF),
• shift processing toward the non-amyloidogenic path in some formulations.
APP is on chromosome 21, so any reduction in amyloidogenic pressure is theoretically relevant to the early AD pathology of DS. This has not been shown in a DS model. sciencedirect.com
Mitochondria and inflammation. DS cells have inefficient respiration and a chronic low-grade inflammatory tone (IL-1β, TNF-α, S100B). Lycopene improves mitochondrial respiration in RCAN1-overexpressing neurons and, in AD rodents, lowers IL-1β/TNF-α while raising IL-10 and TGF-β1. That is consistent with NF-κB suppression already seen in the RCAN1 paper.